98%
921
2 minutes
20
Preclinical models are essential for understanding the pathophysiology of intermittent explosive disorder (IED) in rodents. However, current models fail to fully uncover the molecular mechanisms behind restraint stress-induced aggression. We introduced a restrainer combined with a biting rod to measure IED-associated symptoms in stressed rats. Activation of 5-HT3 receptors promotes aggression by increasing pro-inflammatory cytokines and NF-κB activity in the brain. NF-κB, in turn, upregulates indoleamine 2,3-dioxygenase 1 (Ido1), which converts tryptophan (a serotonin precursor) into kynurenine, depleting serotonin in the amygdala. We examined the roles of 5-HT3 receptors and Ido1 in driving aggression in restraint-stressed rats. Biting behavior in rats was assessed in a restrainer with a biting assembly after ondansetron (5-HT3 antagonist) and minocycline (kynurenine pathway inhibitor) treatments. Pro-inflammatory cytokines and NF-κB levels in the amygdala were measured using ELISA and immunohistochemistry. HPLC quantified kynurenine and tryptophan, while Golgi-Cox staining analyzed dendritic spines. Restraint stress induced extensive biting, elevated pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), and increased NF-κB expression in the amygdala. Elevated kynurenine and decreased tryptophan levels and dendritic spine density were noticed. Blocking 5-HT3 receptors and inhibiting the kynurenine pathway reduced cytokines, kynurenine, and restored tryptophan and spine density. Compared to existing methods, our model offers a more accurate assessment of restraint stress-induced aggression, incorporating molecular pathways and behavioral measures, enhancing understanding of IED. Moreover, stress-induced 5-HT3 signaling may activate NF-κB and kynurenine pathways in the amygdala, potentially contributing to the development of aggressive behavior in rodents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.physbeh.2025.115091 | DOI Listing |
Physiol Behav
September 2025
Department of Pharmacology, School of Pharmacy & Technology Management, SVKM NMIMS Global University, Dhule 424001, Maharashtra, India. Electronic address:
Preclinical models are essential for understanding the pathophysiology of intermittent explosive disorder (IED) in rodents. However, current models fail to fully uncover the molecular mechanisms behind restraint stress-induced aggression. We introduced a restrainer combined with a biting rod to measure IED-associated symptoms in stressed rats.
View Article and Find Full Text PDFEMBO Mol Med
September 2025
Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, 300060, Tianjin, China.
Resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) remains a critical clinical challenge in EGFR mutant lung adenocarcinoma (LUAD). Therefore, it is urgent to explore personalized treatment strategies based on distinct resistance mechanisms to reverse EGFR-TKI resistance. Herein, we found that HER2 S310F mutation contributes to third-generation EGFR-TKI resistance, driven by the accumulation of neurotransmitter 5-hydroxytryptamine (5-HT).
View Article and Find Full Text PDFSci Rep
September 2025
Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, The University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, TX, 78229, USA.
Temporomandibular joint (TMJ) disorders (TMJDs) are linked to heightened nerve sensitivity in TMJ tissues. To set the groundwork for investigating the mechanisms governing this increased responsiveness, this study aimed to identify the types of nerves in the retrodiscal tissue (retrodisc), anterior disc, and joint capsule of mouse TMJ using immunohistochemistry (IHC) and reporter mice. The pan-sensory neuronal marker pgp9.
View Article and Find Full Text PDFCase Rep Oncol
February 2025
Department of Second Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Introduction: An infusion-related reaction (IRR) is an adverse event that typically occurs when cytotoxic drugs or monoclonal antibodies are administered. Palonosetron, a 5-hydroxytryptamine 3 receptor antagonist, is commonly used to prevent chemotherapy-induced nausea and vomiting. IRRs due to palonosetron are very rare, with only two reports of anaphylactic shock due to palonosetron to date.
View Article and Find Full Text PDFCardiovasc Drugs Ther
August 2025
Department of Cardiology, Detroit Medical Center, Detroit, MI, USA.
Selective 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are widely used for managing chemotherapy-induced, post-operative, and radiation-induced nausea and vomiting. The 5-HT3 receptor, a ligand-gated ion channel in the nervous system, regulates vomiting and gastrointestinal motility. Selective antagonists like ondansetron, granisetron, and tropisetron treat chemotherapy and post-surgical nausea, while non-selective antagonists include metoclopramide and prochlorperazine.
View Article and Find Full Text PDF